Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Martin, Svaton"'
Autor:
Lucie Benesova, Renata Ptackova, Tereza Halkova, Anastasiya Semyakina, Martin Svaton, Ondrej Fiala, Milos Pesek, Marek Minarik
Publikováno v:
Pathology and Oncology Research, Vol 28 (2022)
Background: Observation of anticancer therapy effect by monitoring of minimal residual disease (MRD) is becoming an important tool in management of non-small cell lung cancer (NSCLC). The approach is based on periodic detection and quantification of
Externí odkaz:
https://doaj.org/article/089f2946a5c14fe4914df4dad2fe7b16
Autor:
Kristian Brat, Monika Bratova, Jana Skrickova, Magda Barinova, Karolina Hurdalkova, Milos Pesek, Libor Havel, Leona Koubkova, Michal Hrnciarik, Jana Krejci, Ondrej Fischer, Milada Zemanova, Helena Coupkova, Martin Svaton
Publikováno v:
Thoracic Cancer, Vol 11, Iss 11, Pp 3346-3356 (2020)
Background Data regarding real‐life effectiveness of any treatment may improve clinical decision‐making. The aim of this study was to evaluate real‐life effectiveness of tyrosin‐kinase inhibitors, bevacizumab and pemetrexed as first‐line tr
Externí odkaz:
https://doaj.org/article/cbc351e845594ab6848729e0cc8a090b
Autor:
Martin Pesta, Dattatrya Shetti, Vlastimil Kulda, Tereza Knizkova, Katerina Houfkova, Mahyar Sharif Bagheri, Martin Svaton, Jiri Polivka
Publikováno v:
Diagnostics, Vol 12, Iss 8, p 1799 (2022)
The concept of liquid biopsy as an analysis tool for non-solid tissue carried out for the purpose of providing information about solid tumors was introduced approximately 20 years ago. Additional to the detection of circulating tumor cells (CTCs), th
Externí odkaz:
https://doaj.org/article/cc6da66cce884f15bfd64796140cbf8f
Autor:
Leona Koubková, Monika Bratová, Kristián Brat, Martin Svaton, Marie Drosslerova, Jana Krejčí, Juraj Kultan, Magda Barinova, Matyas Wanke, Karolina Hurdalkova
Publikováno v:
Journal of Adolescent and Young Adult Oncology. 11:451-458
Purpose: Aim was to analyze demographic and tumor characteristics, treatment, and survival of patients with lung cancer younger than 40 years of age (U40) compared to older subgroups (41–70 and >70...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63b988255245248cca1d50d616c398a2
https://doi.org/10.1089/jayao.2021.0069
https://doi.org/10.1089/jayao.2021.0069
Autor:
Martin Svaton, Marie Drosslerova, Ondrej Fischer, Miloslav Marel, Michal Hrnciarik, Ondrej Venclicek, Petr Zuna, Michal Svoboda, Jiri Blazek, Monika Bratova, Andrea Mullerova, Bohuslava Vankova, Daniel Krejci
Publikováno v:
Translational Cancer Research. 11:3017-3023
Programmed death-ligand 1 (PD-L1) expression is a standard predictor in the selection of immunotherapy for locally advanced/advanced non-small cell lung cancer (NSCLC). However, comedication with corticosteroids or non-steroidal anti-inflammatory dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3c76b30c1029f4fe5ea5a3bea55b5cb
https://doi.org/10.21037/tcr-22-260
https://doi.org/10.21037/tcr-22-260
Autor:
Miloslav, Marel, Zdenka, Chladkova, Luis Fernando, Casas Mendez, Ondrej, Venclicek, Jana, Skrickova, Ondej, Fischer, Andrea, Mullerova, Libor, Havel, Zuzana, Gyorfy, Michal, Hrnciarik, Michal, Jirousek, Jana, Krejci, Daniel, Krejci, Marcela, Buresova, Jana, Alahakoon, Michal, Svoboda, Martin, Svaton
Publikováno v:
Cancer Diagn Progn
Background/Aim: This study aimed at contributing to a better diagnosis of lung cancer by analyzing the patient’s symptoms and their linkage to other characteristics. Patients and Methods: We analyzed the data of 3,322 patients from LUCAS (LUngCAnce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcbbcfd1d35bc0b8c7f86a95fb3c89a8
https://doi.org/10.21873/cdp.10091
https://doi.org/10.21873/cdp.10091
Autor:
ONDREJ FIALA, JAN BAXA, MARTIN SVATON, LUCIE BENESOVA, RENATA PTACKOVA, TEREZA HALKOVA, MAREK MINARIK, PETR HOSEK, MARCELA BURESOVA, JINDRICH FINEK, JIRI FERDA, MILOS PESEK
Publikováno v:
Cancer Genomics - Proteomics. 19:270-281
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db82bd4c2d614a36ca4d8500be6f29d4
https://doi.org/10.21873/cgp.20319
https://doi.org/10.21873/cgp.20319
Autor:
Josef Vodička, Jan Geiger, Alexandra Židková, Pavel Andrle, Hynek Mírka, Martin Svatonˇ, Tomáš Kostlivý
Publikováno v:
Annals of Thoracic and Cardiovascular Surgery. 28:171-179
The aims of this work were the retrospective analysis of a cohort of patients with acute mediastinitis treated at the authors' worksite over a 15-year period and the identification of factors that significantly affect the outcomes of the therapy.Duri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7b6e226107b2ddeae3a310377884d75
https://doi.org/10.5761/atcs.oa.21-00147
https://doi.org/10.5761/atcs.oa.21-00147
Autor:
Denisa Rozsivalova, Jana Alahakoon, Juraj Kultan, Andrea Mullerova, Kristián Brat, Daniel Krejci, Ondrej Venclicek, Libor Havel, Martin Svaton, Martina Vasakova, Petra Smickova, Ondrej Fischer, Kristyna Hrda, Jana Skrickova, Zsuzsanna Gyorfy, Miloslav Marel, Gabriela Krakorova, P. Opálka, Michal Hrnčiarik, Jaroslav Duba, Jiri Silar, Michal Svoboda, Michal Jirousek, Petr Zuna, J. Krejčí, Lydia Zarnayova
Publikováno v:
Anticancer Research. 41:5549-5556
Background/aim LUCAS is a clinical lung cancer registry (ClinicalTrials.gov identifier is NCT04228237), prospectively collecting data from newly diagnosed lung cancer patients in seven pneumooncology centers in the Czech Republic, since June 1, 2018.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f45687a837ce2677c1d91847fb2d1fe
https://doi.org/10.21873/anticanres.15368
https://doi.org/10.21873/anticanres.15368
Prognostic Value ofEGFRExon-20 Insertions in Czech Patients With Advanced Non-small Cell Lung Cancer
Autor:
Marketa Cernovska, Leona Koubková, Kristina Sandstrom, Jana Krejčí, Martin Svaton, Monika Bratová, Jiri Blazek, Jana Skrickova, P. Opálka, Helena Čoupková, Michal Hrnčiarik, Ondrej Fischer, Karolina Hurdalkova, Daniel Dolezal, Tana Tuzova, Magda Barinova, Milada Zemanova, Péter Kunovszki, Lubos Holubec, Miloš Pešek, P. Mahadevia
Publikováno v:
Anticancer Research. 41:5625-5634
Background/aim Per literature, patients with epidermal growth factor receptor (EGFR) exon-20 insertions respond poorly to tyrosine kinase inhibitors (TKIs). This study analyzed real-world data to examine the prognostic and predictive value of these m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aba859470439e22e1b459a0e725153a0
https://doi.org/10.21873/anticanres.15378
https://doi.org/10.21873/anticanres.15378